Murayama Y, Kawai K, Nakamura S, Yamashita K
Division of Endocrinology and Metabolism, University of Tsukuba, Ibaraki, Japan.
Diabetes Res Clin Pract. 1990 May-Jun;9(2):129-36. doi: 10.1016/0168-8227(90)90104-2.
Urinary C-peptide excretion (U-C-peptide) was measured in order to examine the changes in endogenous insulin secretion after the beginning of insulin therapy. U-C-peptide in the 24-h urine (TU-C-peptide) of non-insulin-dependent diabetes mellitus (NIDDM) patients was measured on the 6,7,8th (period-A), 13,14,15th (period-B) and 20,21,22nd day (period-C) after admission. The TU-C-peptide of NIDDM patients, newly receiving insulin therapy from the 9th day, decreased to 58.7 +/- 6.2% (mean +/- SEM) of its basal level (period-A, 19.8 +/- 3.8 nmol/day) at period-B and remained at the same level at period-C, although U-C-peptide in the urine collected between 04.00 h and 06.30 h did not decrease significantly. Their plasma C-peptide levels from 2-5 h after the ingestion of a mixed meal at period-C decreased significantly compared with those at period-A. On the other hand, the TU-C-peptide of NIDDM patients who continued therapy with insulin or sulfonylureas in the outpatient clinic at period-B and -C did not decrease significantly from the basal level at period-A, although fasting plasma glucose decreased to the same level in both groups of patients. These results suggest that the endogenous insulin secretion after food ingestion is suppressed during insulin therapy in NIDDM patients.
为了研究胰岛素治疗开始后内源性胰岛素分泌的变化,检测了尿C肽排泄量(U-C肽)。对非胰岛素依赖型糖尿病(NIDDM)患者入院后第6、7、8天(A期)、第13、14、15天(B期)和第20、21、22天(C期)的24小时尿U-C肽(TU-C肽)进行了检测。从第9天开始新接受胰岛素治疗的NIDDM患者,其TU-C肽在B期降至基础水平(A期,19.8±3.8 nmol/天)的58.7±6.2%(平均值±标准误),在C期维持在同一水平,尽管在04:00至06:30收集的尿U-C肽没有显著下降。与A期相比,C期混合餐摄入后2至5小时他们的血浆C肽水平显著下降。另一方面,在B期和C期继续在门诊接受胰岛素或磺脲类药物治疗的NIDDM患者,其TU-C肽与A期的基础水平相比没有显著下降,尽管两组患者的空腹血糖都降至相同水平。这些结果表明,NIDDM患者在胰岛素治疗期间,进食后内源性胰岛素分泌受到抑制。